Applications published 4 February 2009

Coatings containing multiple drugs
Micelle Technologies 2019657*

Systems and methods of microfluidic membraneless exchange using filtration of extraction fluid, outlet streams
Columbia University 2019658*

Systems and methods for wound management
KCI Licensing 2019660*

• Warning system for timely administration of drugs that have to be administered at certain times
Kiran, Kazim 2019662*

• Compsns comprising at least one naphthoic acid derivative and benzoyl peroxide, methods for preparing same, and uses thereof
Galderma Research & Development 2019663*

• Stable pharmaceutical compsn containing docataxel and a method of manufacturing the same
SK Chemicals 2019664*

• Drug release from nanoparticle-coated capsules
University of South Australia 2019665*

• Pharmaceutical preparations for transdermal use
Alma Mater Studiorum -Universita" di Bologna 2109666*

• Detection and imaging of target tissue
Barnes-Jewish Hospital 2019667*

• Pharmaceutical compsn comprising candesartan cilexetil
Teva Pharmaceutical Industries 2019668*

• Oral preparation comprising pioglitazone
Takeda Pharmaceutical 2019669*

• Microspheroidal-controlled release of biomolecules
The Trustees of the University of Pennsylvania 2019670*

• Bivalent SMAC mimetics and the uses thereof
The Regents of the University of Michigan 2019671*

• Unit dose formulations comprising an inhalable solution of albuterol
Tika Laekemdel 2019672*

• Compounds for the treatment of metabolic disorders
Wellstat Therapeutics 2019673*

• Histone deacetylase and tubulin deacetylase inhibitors
The President and Fellows of Harvard College 2019674*

• Methods for treating or preventing neoplasias
Merck Frosst Canada 2019675*

• Method for increasing the bioavailability of benzhydryl piperazine containing compounds
Neuromed Pharmaceuticals 2018676*

• Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
Merck & Co 2019677*

• Novel silicone film former for delivery of actives
Dow Corning 2019678*

• Glucose transport inhibitors and methods of use
Theracos 2019679*

• Compsns comprising biomembrane sealing agent for treatment of neuronal injury and methods of use
Warsaw Orthopaedic 2019681*

• Cytokine mediating compsn
Cambridge Scientific 2019682*

• Administration of growth factors for the treatment of CNS disorders
The Regents of the University of California 2019683*

• Methods and compsns based on shiga toxin type 1 protein
The Henry M Jackson Foundation for the advancement of Military Medicine 2019684*

• Defective interfering virus
The University of Warwick 2019685*

• Combined mucosal and parenteral immunisation against HIV
Novartis 2019686*

• Vaccine against streptococci
Merial 2019687*

• Use of cathepsin K antagonists in bone production
Velcura Therapeutics 2019688*

• Pharmaceutical compsn and vaccine against staphylococcal infections
GlaxoSmithKline Biologicals; The Brigham & Women's Hospital 2019689*

• Preparation of polymer conjugates of VLA-4 antagonists via a Mitsubonu's Reaction
Elan Pharmaceuticals 2019690*

• Polymers for functional particles
Massachusetts Institute of Technology; The Brigham and Women's Hospital 2019691*

• Compounds and methods for modulating expression of GCCR
Isis Pharmaceuticals 2019692*

• High molecular weight chelation structure
Canadian Blood Services 2019693*

• Process for the preparation of R-(+)-3-(carbamoyl-methyl)-5-methylhexanoic acid and salts thereof
Teva Pharmaceutical 2019817*

• Process for the production of compounds via hazardous intermediates in a series of microreactors
DSM IP 2019818*

• Novel peptide derivatives useful as antimicrobial agents for treating wounds
Neobiotics 2019819*

• Therapeutic pyrrolidine compounds
Allergan 2019820*

• Process for continuously preparing N-ethyl-2-pyrrolidone (NEP)
BASF SE 2019821*

• A new process for the synthesis of 2-aminoxazole compounds
AB Science 2019822*

• Benzamide glucokinase activators
Transtech Pharma 2019823*

• Benzamide glucokinase activators
Transtech Pharma 2019824*

• Inhibitors of human immunodeficiency virus replication
Boehringer Ingelheim International 2019825*

• Thiophene-carboxamides useful as inhibitors of protein kinases
Vertex Pharmaceuticals 2019826*

• Integrase inhibitors 3
Avexa 2019827*

• N-(2-thiazolyl)-amide derivatives as GSK-3-inhibitors
Noscira 2019828*

• N-(2-thiazolyl)-amide derivatives as GSK-3 inhibitors
Noscira 2019829*

• Inhibitors of secretion of hepatitis B virus antigens for treatment of a chronic hepatitis virus
Institute for Hepatitis and Virus Research; Drexel University 2019830*

• Nicotinic acetylcholine receptor ligands 101
AstraZeneca 2019831*

• Process for the preparation of pyrazolylaminoquinazoline derivatives comprising a phosphate group
AstraZeneca 2019832*

• Process for the production of esters of sugar and sugar derivatives
Sebus 2019833*

• Ectonucleotidase inhibitors
Rheinische Friedrich-Wilhelms-Universitaet Bonn 2019834*

• Oligonucleotides affecting expression of phosphodiesterases
Topingen Pharmaceuticals 2019835*

• Methods, compsns and kits for detecting protein aggregates
Applera 2019836*

• Compounds and compsns as channel activating protease inhibitors
IRM LLC 2019837*

• Primers for use in detecting metallo-beta-lactamases
Crieghton University 2019838*

• Methods and compsns for gene inactivation
Sangamo BioSciences 2019839*

• Antagonistic anti-human CD40 monoclonal antibody
PanGenetics 2019840*

• Antagonistic anti-CD40 antibody pharmaceutical compsns
Novartis; Xoma Technology 2019841*

• Immunosuppressant binding antibodies and methods of obtaining and using same
Abbott Laboratories 2019842*

• Low molecular weight heparin compsn and uses thereof
Momenta Pharmaceuticals 2019843*

• New synergistic pharmaceutical compsn
AstraZeneca 2019855*

• Chemically defined culture medium for neisseria
Health Protection Agency 2019856*

• CD40 agonist antibody/type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
The Regents of the University of California 2019857*

• Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
BioE; Regents of the University of Minnesota 2019858*

• Adipose derived adult stem cells in hepatic regeneration
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College 2019859*

• Protein production using eukaryotic cell lines
Hiprocell 2019860*

• Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimised glycosylation activity
Universite de Provence (Aix-Marseille); Centre National de la Recherche Scientifique 2019864*

• Stable vaccine formulation
Arecor 2019865*

• Delta-5 desaturase from peidinium sp and its use in making polyunsaturated fatty acids
EI du Pont de Nemours 2019866*

• Method of multiparallel construction of host/vector-systems for expression of proteins
GL Bioteknik 2019867*

• Process for the preparation of L-methionine
Evonik Degussa 2019868*

• Fermentative production of lipostatin
KRKA 2019869*

• Sample control for correction of sample matrix effects in analytical detection methods
Koninklijke Philips Electronics 2019870*